Search - tctmd.com

Displaying 561 - 580 of 1128

Sort: Relevancy | Date

News Daily News

No Downside to Medicare Penalties for Hospital Readmissions for HF, Acute MI

Ashley Lyles

July 18, 2017

News Daily News

ECGs Ordered After One in Five Annual Health Exams

Shelley Wood

July 13, 2017

News Daily News

Identifying CAD in Stable Patients: CT Imaging or Start With Functional Testing?

Yael L. Maxwell

July 12, 2017

News Daily News

Obamacare Implementation Linked to Lower Rates of Cardiac Arrest

L.A. McKeown

July 05, 2017

News Daily News

Real-World TEVAR Population Shows Female Sex Independently Predictive of Mortality

L.A. McKeown

July 04, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

News Conference News TVT 2017

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Michael O'Riordan

June 16, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

News Daily News

CMS Lauded for Coverage Decision on Supervised Exercise Therapy for PAD

L.A. McKeown

June 08, 2017

News Daily News

FDA Clears Sentinel Cerebral Protection Device for Use During TAVR

Shelley Wood

June 05, 2017

News Daily News

Post-MI High-Intensity Statin Use Has Doubled in Recent Years

Michael O'Riordan

May 30, 2017

News Daily News

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

Todd Neale

May 11, 2017

News Daily News

Debate Continues Over How Best to Prevent Stroke in Patients With Carotid Stenosis

Todd Neale

May 01, 2017

News Daily News

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

Michael O'Riordan

April 27, 2017

News Daily News

One in Five Acute MI Patients Drop Statins Within 2 Years

Michael O'Riordan

April 20, 2017

News Daily News

Comrades in TAVR? Cardiac Surgeons Say They’re Involved in All Stages of TAVR Care

Yael L. Maxwell

April 14, 2017

News Daily News

Running a Risk: Marathon Cities See Treatment Delays, More Cardiac Deaths Among Non-Race Participants

Shelley Wood

April 13, 2017

News Daily News

Do NOACs Carry a Higher Risk of Acute MI? New Study Reopens Old Questions

Todd Neale

March 28, 2017

News Conference News ACC 2017

MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns

L.A. McKeown

March 27, 2017

News Conference News ACC 2017

Many Patients Prescribed PCSK9 Inhibitors Never End Up Getting Them

Yael L. Maxwell

March 23, 2017

Advertisement

No Downside to Medicare Penalties for Hospital Readmissions for HF, Acute MI

ECGs Ordered After One in Five Annual Health Exams

Identifying CAD in Stable Patients: CT Imaging or Start With Functional Testing?

Obamacare Implementation Linked to Lower Rates of Cardiac Arrest

Real-World TEVAR Population Shows Female Sex Independently Predictive of Mortality

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

CMS Lauded for Coverage Decision on Supervised Exercise Therapy for PAD

FDA Clears Sentinel Cerebral Protection Device for Use During TAVR

Post-MI High-Intensity Statin Use Has Doubled in Recent Years

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

Debate Continues Over How Best to Prevent Stroke in Patients With Carotid Stenosis

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

One in Five Acute MI Patients Drop Statins Within 2 Years

Comrades in TAVR? Cardiac Surgeons Say They’re Involved in All Stages of TAVR Care

Running a Risk: Marathon Cities See Treatment Delays, More Cardiac Deaths Among Non-Race Participants

Do NOACs Carry a Higher Risk of Acute MI? New Study Reopens Old Questions

MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns

Many Patients Prescribed PCSK9 Inhibitors Never End Up Getting Them

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content